1. Home
  2. PUMP vs FTRE Comparison

PUMP vs FTRE Comparison

Compare PUMP & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProPetro Holding Corp.

PUMP

ProPetro Holding Corp.

HOLD

Current Price

$15.77

Market Cap

1.0B

Sector

Energy

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$15.34

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PUMP
FTRE
Founded
2007
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
829.3M
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
PUMP
FTRE
Price
$15.77
$15.34
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$14.14
$14.06
AVG Volume (30 Days)
4.2M
1.4M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
100.76
N/A
EPS
N/A
N/A
Revenue
$1,269,158,000.00
$2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$15.61
$3.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.00
52 Week Low
$4.51
$3.97
52 Week High
$18.50
$18.67

Technical Indicators

Market Signals
Indicator
PUMP
FTRE
Relative Strength Index (RSI) 50.95 81.98
Support Level $14.90 $8.85
Resistance Level N/A $18.26
Average True Range (ATR) 1.03 0.89
MACD -0.18 0.61
Stochastic Oscillator 34.90 91.00

Price Performance

Historical Comparison
PUMP
FTRE

About PUMP ProPetro Holding Corp.

ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: